טוען...

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients

Hepatitis B virus (HBV) reactivation has been noted in HBV surface antigen (HBsAg)-seronegative patients with CD20(+) B-cell non-Hodgkin lymphoma (NHL) undergoing rituximab treatment. Clinically, hepatitis flares are usually associated with the reappearance of HBsAg (reverse seroconversion of HBsAg,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Medicine (Baltimore)
Main Authors: Hsiao, Liang-Tsai, Wang, Hao-Yuan, Yang, Ching-Fen, Chiou, Tzeon-Jye, Gau, Jyh-Pyng, Yu, Yuan-Bin, Liu, Hsiao-Ling, Chang, Wen-Chun, Chen, Po-Min, Tzeng, Cheng-Hwai, Chan, Yu-Jiun, Yang, Muh-Hwa, Liu, Jin-Hwang, Huang, Yi-Hsiang
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer Health 2016
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839912/
https://ncbi.nlm.nih.gov/pubmed/26986131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003064
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!